Antiepileptic drugs and carnitine;Farmacos antiepilepticos y carnitina

Revista de Neurologia

Volumn 30, Issue SUPPL. 1, 2000, Pages

  Campistol, J ^a,c   Chavez B ^a   Vilaseca, M A ^b   Artuch, R ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Antiepileptic drugs; Carbamazepine; Carnitine; Ketogenic diet; L carnitine; Phenobarbital; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARNITINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ABSORPTION; CONFERENCE PAPER; DRUG ANTAGONISM; EPILEPSY; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; KETOGENESIS; METABOLIC DISORDER; MITOCHONDRIAL MEMBRANE; ADOLESCENT; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; MALE; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; ANTICONVULSANTS; CARNITINE; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; PHENOBARBITAL; VALPROIC ACID;

EID: 0033915606     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperamonemia associated with valproate therapy. J Pediatr 1982; 101: 782-5.
2. Coulter DL. Carnitine, valproate and toxicity. J Child Neurol 1991; 6: 7-14.
3. De Vivo, Bohan T, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 1998; 39: 1216-25.
4. Rodríguez-Segade S, de la Pena CA, Tutor JC, et al. Carnitine deficiency associated with anticonvulsant therapy. Clin Chim Acta 1989; 181: 175-82.
5. Opala G, Winter S, Vance C, et al. The effect of valproic acid on plasma carnitine levels. Am J Dis Child 1991; 145: 999-1001.
6. Castro-Gago M, Novo I, Rodríguez-Segade S. Effects of valproic acid on the urea cycle and carnitine metabolism. Int Pediatr 1990; 5: 54-7.
7. Stadler D, Bale JF, Chenard C, et al. Effect of long term valproic acid administration on the efficiency of carnitine reabsorption in humans. Metabolism 1999; 48: 74-9.
8. Camiña MF, Rozas I, Castro-Gago M, et al. Alteration of renal carnitine metabolism by anticonvulsant treatment. Neurology 1991; 41: 1444-8.
9. Castro-Gago M, Bernabeu FA, Novo I, Camiña F, Eirís J, Rodríguez-Segade S. Efecto de los fármacos anticomiciales sobre el metabolismo renal de la carnitina. Rev Neurol 1994; 22: 646-50.
10. Artuch R, Quintana M, Moyano D. Determinación de carnitina en plasma por un procedimiento espectrométrico. Valores de referencia para una población pediátrica. Quimica Clinica 1997; 16: 397-400.
11. Castro-Gago M, Eirís J, Novo MI, et al. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine and phenobarbital. J Child Neurol 1998; 13: 546-9.
12. Kelley RI. The role of carnitine supplementation in valproic acid therapy. Pediatrics 1994; 93: 891-2.
13. Riva R, Albani F, Gobbi G, et al. Camitine disposition before and during valproate therapy in patients with epilepsy. Epilepsia 1993; 34: 184-7.
14. Pons R, De Vivo DC. Primary and secondary carnitine deficiency syndromes. J Child Neurol 1995; 10 (Suppl 2): S8-24.
15. Zelnik N, Fridkis I, Gruener N. Reduced carnitine and antiepileptic drugs: cause relationship or co-existence. Acta Paediatr 1995; 84: 93-5.
16. Tein I, Di Mauro S, Xie ZW, et al. Valproic acid impairs carnitine uptake in cultured human skin fibroblasts: an in vitro model for the pathogenesis of valproic acid associated carnitine deficiency. Pediatr Res 1993; 34: 281-7.
17. Sakemi K, Takad G. Effect of carnitine on valproic acid concentrations in serum, brain and liver. Pediatr Neurol 1998; 18: 331-3.
18. Hug G, McGraw CA, Bates SR, et al. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin and carbamazepine in children. J Pediatr 1991; 119: 779-802.
19. Schmidt-Sommerfeld E, Werner D, Penn D. Carnitine plasma concentrations in 353 metabolically healthy children. Eur J Pediatr 1988; 147: 356-60.
20. Dreifuss FE, Santilli N, Langer DH, et al. Valproic acid hepatic fatalities: a retrospective review. Neurology 1987; 37: 379-85.
21. Freeman JH, Vining EPG, Cost S, et al. Does carnitine administration improve the symptoms attributed to anticonvulsant medications?: a double-blinded, crossover study. Pediatrics 1994; 93: 893-5.
22. Bohles H, Sewell AC, Wenzel D. The effect of carnitine supplementation in valproic-induced hyperamonemia. Acta Paediatr 1996; 85: 446-9.
23. Prasard AN, Safstrom CE, Holmes GL. Alternative epilepsy therapeutics: the ketogenic, immunoglobulins, and steroids. Epilepsia 1996; 37 (Suppl 1): S581-95.
24. Campistol J, Fernández A, Ortega J. Estado de mal convulsivo en el niño. Experiencia con valproato endovenoso. Actualización del protocole de tratamiento. Rev Neurol 1999; 29: 359-65.